MVA-HPV

N/A

Report date: 2022/11/20 15:02:34

Base Information

Drug NameMVA-HPV
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCervical Intraepithelial NeoplasiaPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited KingdomEstonia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBarinthus Biotherapeutics PLC
China Registration ClassN/A

Develop Information

Active CompaniesBarinthus Biotherapeutics PLC
Inactive CompaniesN/A
Active IndicationsCervical Intraepithelial NeoplasiaPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A